New COPD Drug Cuts Flare-Ups 34% in Major Trial

A breakthrough treatment for chronic lung disease has shown remarkable results, slashing severe breathing attacks by up to 34% regardless of smoking history.

The drug, now awaiting FDA review, could transform life for millions living with COPD.